Efforts to advance cancer research and treatment are highlighted by multiple clinical trials and expansions in production facilities. These initiatives encompass various types of cancer, including lung, breast, prostate, gastric, and glioblastoma.
Opened NOVA, world's largest
Lu-177 facility in Germany
Opened new Lu-177
production site in Belgium
Announced new N.A. facility
dedicated to Lu-177 Production
Lutetium Trials
-Prostate
-Renal
1 Lutetium trial on NETs (mid-gut)
posted as Progenics - bought by Lantheus)
Lantheus
FutureChem
Pilochem | Seibersdorf
Jubliant
2 Trials - Prostate Cancer
Telix Pharma
RadioPharm
2 Trials
Lung Cancer (non-small cell)
Breast/Gastric
Trial not found in database; preclinical
Clinical Trials
Commercial seller
Producer/Manufacturer
Reactor
1 Trial - Solid Tumours
Trial not found in database
ImaginAB
Adding 4 production sites in 2023
- 3 commercial supply
- 1 research/clinical
"Clinical trials of its therapeutic candidates for solid and hematologic malignancies"
Trial not found in database
11 Other Trials:
4 Neuroblastoma/Glioblastoma
Nasopharyngeal Cancer
Lung Cancer
Breast Cancer
Merkel Cell Carcinoma
Neoplasms
Carcinoid Heart Disease
'Solid Tumour' (Novartis acquired Clovis)
13 Prostate
5 under Endocyte (acquired by Novartis)
